Profile
Substance use treatment; Transitional housing, halfway house, or sober home; Residential/24-hour residential; Long-term residential; Buprenorphine used in Treatment; Naltrexone used in Treatment; No formal relationship with prescribing entity; This facility administers/prescribes medication for alcohol use disorder; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Acamprosate (CampralĀ®); Disulfiram; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Medications for HIV treatment; Medications for Hepatitis C treatment; Nicotine replacement; Non-nicotine smoking/tobacco cessation; Anger management; Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling; 12-step facilitation; Private for-profit organization; State Substance use treatment agency; State department of health; Commission on Accreditation of Rehabilitation Facilities (CARF); Federal, or any government funding for substance use treatment programs; Medicaid; Cash or self-payment; Adult men; Clients with co-occurring mental and substance use disorders; Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge; Self-help groups; Housing services; Assistance with obtaining social services; Mentoring/peer support; Substance use disorder education; Individual counseling; Group counseling; Family counseling; Smoking permitted in designated area; Adults; Young adults; Male; Social skills development